This relationship is particularly important as insulin activates multiple pathways involved in aggressive breast cancer biology, including PI3K (Phosphoinositide 3‐kinase)/Akt (Protein kinase B) and (Mitogen‐activated protein kinase) pathways, which regulate cell growth, proliferation, survival, and metabolism [59, 60]. The gene discussed is INS; the disease is breast carcinoma.